Medical-grade absorbable sutures made of 99.9% pure Polydioxanone (PDO), featuring 27G/50mm surgical needles with 70mm screw-structured threads. Clinically proven to stimulate type I/III collagen production within 4-8 weeks, achieving 82% patient satisfaction in skin elasticity improvement (2023 clinical trial data). FDA-cleared material with 6-8 month biodegradation cycle.

Dual-Action Efficacy

Advanced mono-filament manufacturing ensures:
• 150N tensile strength durability
• 0°-15° variable insertion angles
• 50mm depth-controlled needle penetration
• ISO 13485 certified production

1. Sterilize treatment area with chlorhexidine 2%
2. Administer 5-8 threads per facial quadrant
3. Maintain 5mm subcutaneous placement
4. Post-op cold compress application
※ 12-month stability: 3-5 sessions recommended

*For licensed medical practitioners only. Clinical outcomes may vary 15-20% based on individual tissue response and technique. Post-market surveillance data shows 92% efficacy in mid-face lifting when combined with proper aftercare. Notify manufacturer immediately regarding any adverse events.